Aspirin cuts liver fat in clinical trial retrieved 25 March 2024 from https://medicalxpress.com/news/2024-03-aspirin-liver-fat-clinical-trial.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.Study shows that low-dose aspirin associated with a 15% lower risk of developing diabetes in people aged over 65 yearsUse this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page.
Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.to let the recipient know who sent the email. Neither your address nor the recipient's address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form.Get weekly and/or daily updates delivered to your inbox.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Key protein identified in protecting women from fatty liver diseaseNew research from Karolinska Institutet in Sweden shows how oestrogen protects against MASLD, a fatty liver disease that has increased dramatically during the current obesity epidemic.
Source: NewsMedical - 🏆 19. / 71 Read more »
Study shows how estrogen protects against fatty liverNew research from Karolinska Institutet shows how estrogen protects against MASLD, a fatty liver disease that has increased dramatically during the current obesity epidemic. The study, published in Molecular Systems Biology, shows how a new drug under development could become a future treatment for fatty liver disease and liver cancer.
Source: medical_xpress - 🏆 101. / 51 Read more »
Experts help bring first-of-its-kind drug for metabolic liver disease to the clinicLiver disease specialists at the University of Chicago Medicine will soon begin prescribing a first-of-its-kind drug for treating advanced metabolic dysfunction-associated steatotic liver disease (MASLD)—formerly known as nonalcoholic fatty liver disease (NAFLD).
Source: medical_xpress - 🏆 101. / 51 Read more »
Overeating and starving both damage the liver: Cavefish provide new insight into fatty liver diseaseFatty liver, which can lead to liver damage and disease, can occur from both overeating and starvation. Now, new research shows how naturally starvation-resistant cavefish, unlike other animals, are able to protect their liver and remain healthy. The findings have implications for understanding and potentially addressing liver conditions in humans.
Source: medical_xpress - 🏆 101. / 51 Read more »
Quibim introduces QP-Liver for enhancing liver disease diagnosis through MRI analysisQuibim, a global company pioneering imaging biomarkers for precision medicine, is today announcing the launch of a new product, QP-Liver, which improves the diagnosis of diffuse liver diseases through highly accurate quantification of tissue fat and iron from MRI scans.
Source: NewsMedical - 🏆 19. / 71 Read more »